NCT02562144View on ClinicalTrials.gov

A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 5, 2016

Primary Completion Date

April 6, 2016

Study Completion Date

April 7, 2016

Conditions
Pain
Interventions
DRUG

Xylocaine spray

Cutaneous xylocaine spray before intravenous cannulation.

DRUG

Placebo

Cutaneous placebo before intravenous cannulation.

All Listed Sponsors
lead

Isala

OTHER

NCT02562144 - A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults | Biotech Hunter | Biotech Hunter